Year: 2026

FY 2025/26 results in line with preliminary figures released on 16 April: Record commercial performance, challenging execution on some rolling stock contracts, cash in line with guidanceRecord order intake1 of €27.6 billion, book-to-bill ratio of 1.4 and backlog of €104.4 billion Group sales of €19,171 million, up 3.7%, of which 7.2% on an organic basis1 Adjusted EBIT1 of €1,168 million, broadly stable compared to the prior fiscal year Adjusted EBIT margin1 of 6.1%, down 30bps Y/Y, stable at constant currency and scope. Planned margin expansion impacted by lower production and some rolling stock projects. Net profit (Group share) of €324 million, compared to €149 million in FY 2024/25 Free Cash Flow1 of €336m, in line with guidance, despite contract working capital headwindsFY 2026/27 outlook: Priority actions on execution, progress...

Meudon (France), May 13th, 2026 Vallourec, a world leader in premium seamless tubular solutions, announces today its results for the first quarter 2026. The Board of Directors of Vallourec SA, meeting on May 12th 2026, approved the Group’s first quarter 2026 Consolidated Financial Statements. First Quarter 2026 ResultsQ1 Group EBITDA of $220m or €187m, above guidance midpoint Strong 22.6% EBITDA margin, up ~200bps sequentially Solid cash generation of $135m, net cash position of $67m post $107m buyback Resilient customer activity in primary Middle East markets with no cancellations; select order postponements and shipping delays impacting invoicing cadence Higher activity levels emerging in US, leading to increasing market pricing Q2 2026 Group EBITDA expected to range between $175 million and $205 million Vallourec confirms intention...

COPENHAGEN, Denmark, May 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2026.Revenue for the first three months was DKK 1,058 million, comprised of:DKK 721 million from Travel Health, an increase of 14% compared to the first quarter of 2025 when adjusting for discontinued partnership revenue. The growth was primarily driven by increased demand for rabies vaccines and the continued launch of the chikungunya vaccine. DKK 294 million from Public Preparedness, a decrease of 53% compared to the first quarter of 2025, which is in line with expectations as 2026 is expected to be a normalized year for this business without material impact from mpox outbreaks. DKK 44 million in other revenue.The operating profit (EBITDA) was DKK 165 million, corresponding...

COMPANY ANNOUNCEMENT NO. 24-2026FLSmidth & Co. A/S13 May 2026Copenhagen, DenmarkToday, the Board of Directors of FLSmidth & Co. A/S (FLSmidth) have approved the Q1 2026 Interim Financial Report. In Q1 2026, FLSmidth reported organic revenue growth of -7% and an Adjusted EBITA margin of 15.2%. The financial guidance for the full year 2026 is maintained. Highlights in Q1 2026:Order intake increased organically by 8% compared to Q1 2025 driven by the Service and Pumps, Cyclones & Valves (PC&V) businesses, growing organically by 19% and 16%, respectively. Total order intake increased by 3% compared to Q1 2025. Revenue decreased organically by 7% compared to Q1 2025 driven by timing and order mix in recent quarters. Total revenue decreased by 12% compared to Q1 2025. The Adjusted EBITA margin was 15.2% in Q1 2026 compared...

Highlights first quarter 2026Solid start to the year with group turnover amounting to 1,016 million euros, up 2% compared to 993 million euros a year ago Order book remains at a healthy level at 7.4 billion euros, compared to 7.6 billion euros a year ago and at the end of 2025 Management reaffirms guidance for the year for turnover and EBITDA margin in line with 2025 DEME’s new offshore transport and installation vessel Norse Wind commenced its first assignment in April 2026, while Norse Energi was delivered on schedule and within budgetAttachmentP2026 DEME Trading update Q1 2026 ENG

Total product sales of €30.5 million Cash position of €105.3 million as of end March 2026, excluding proceeds from successful reserved offering completed in April 20261 Program launched in April to further reduce operating expenses Pfizer expected to file regulatory submissions for Lyme disease vaccine candidateLyon (France), May 13, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported its financial results for the first quarter ended March 31, 2026, provided key corporate updates, and updated its 2026 financial guidance. The condensed consolidated interim financial results are available on the Company’s website (Financial Reports – Valneva). Valneva will provide a live webcast of its first quarter 2026 results conference call beginning at 3 p.m. CEST/9 a.m. EDT today. This webcast will...

Marimekko Corporation, Interim Report, 13 May 2026 at 8.00 a.m. EEST INTERIM REPORT OF MARIMEKKO, 1 Jan–31 Mar 2026: Marimekko’s net sales and operating profit in the first quarter grew despite the continued challenging market situation This release is a summary of Marimekko’s interim report for the January–March period of 2026. The complete report is attached to this release as a pdf file and it is also available on the company’s website at company.marimekko.com under Releases & publications. The first quarter in briefMarimekko’s net sales increased by 5 percent and totaled EUR 41.4 million (39.6). Net sales were boosted in particular by increased wholesale sales in Scandinavia and Finland. In total, international sales increased by 9 percent as retail sales grew in all and wholesale sales in nearly all international market areas. Net...

Trondheim, 13 May 2026: In the first quarter, NORBIT recorded revenues of NOK 732.1 million, an increase of 40 per cent from the corresponding quarter of 2025. The EBIT result was NOK 155.9 million, representing a margin of 21 per cent. Diluted earnings per share were NOK 1.73 for the first quarter, up from NOK 1.40 one year earlier. * The Oceans segment delivered revenues of NOK 203.6 million, a decrease of 12 per cent from the same quarter in 2025, with an EBIT margin of 25 per cent. * The Connectivity segment reported NOK 211.4 million in revenues, an increase of 45 per cent from the corresponding quarter of 2025, and an EBIT margin of 27 per cent. * The Product Innovation & Realization (PIR) segment saw revenue growth of 111 per cent to NOK 339.0 million, with an EBIT margin of 20 per cent. “2026 has started with a high...